AKT1 and metabolic dysfunction-associated steatotic liver disease: Integrative analysis highlighted lipid-related mechanisms (cellular lipid response, PI3K-AKT signaling, insulin resistance, and non-alcoholic fatty liver disease) and inflammation-associated pathways (TNF/IL-17 signaling).